Philip LoGrasso - Carlsbad CA, US Steven Xanthoudakis - Beaconsfied, CA John Tam - Montreal, CA Sarah Harper - Bishop Stortford, GB James Bilsland - Bishop's Storford Hertfordshire, GB Lisa Young - Harlow, GB
A method of promoting neuronal survival and helping prevent neuronal death administers (di-substituted-phenyl) pyrimidinyl imidazole derivative compounds represented by effective to inhibit the activity of c-jun-N-terminal kinase.
Substituted Pyrimidinyl-Amines As Protein Kinase Inhibitors
Theodore M. Kamenecka - Palms Beach Gardens FL, US Rong Jiang - Fuquay Varina NC, US Xinyi Song - Jupiter FL, US Philip LoGrasso - Jupiter FL, US Michael D. Cameron - Port nSt. Lucie FL, US Derek R. Duckett - Jupiter FL, US
The present invention provides novel substituted pyrimidinyl-amines that are useful as inhibitors of protein kinases, especially c-Jun N-terminal kinases (JNK) and pharmaceutical compositions thereof and methods of using the same for treating conditions responsive to the inhibition of the JNK pathway.
Yangbo Feng - Palm Beach Gardens FL, US Philip LoGrasso - Jupiter FL, US Thomas Bannister - Palm Beach Gardens FL, US Thomas Schroeter - Riviera Beach FL, US Xingang Fang - Riviera FL, US Yen ting Chen - Palm Beach Gardens FL, US Yan Yin - Jupiter FL, US Michael P. Smolinski - Port St. Lucie FL, US Lei Yao - Tianjin, CN Bo Wang - Collegeville PA, US Hampton Sessions - Orlando FL, US
Compounds useful as Rho kinase inhibitors of formula (I): wherein variable are as defined herein are provided. Methods of treatment of malconditions mediated by Rho kinase, and methods of preparation of the compounds, are also provided.
Benzimidazoles And Analogs As Rho Kinase Inhibitors
Yangbo Feng - Palm Beach Gardens FL, US Philip LoGrasso - Jupiter FL, US Thomas Bannister - Palm Beach Gardens FL, US Thomas Schroeter - Riviera Beach FL, US Hampton Sessions - Orlando FL, US Lei Yao - Tianjin, CN Bo Wang - Collegeville PA, US Michael P. Smolinski - Port St. Lucie FL, US Yen Ting Chen - Palm Beach Gardens FL, US Yan Yin - Jupiter FL, US Bozena Frackowiak-Wojtasek - Dobrzen Wielki, PL Sarwat Chowdhury - Palm Beach Gardens FL, US
Compounds useful as Rho kinase inhibitors according to formula IA or IB: wherein A, B, D, E, R, Rand Arare as defined herein, and any tautomer, salt, stereoisomer, hydrate, solvent, or prodrug thereof, pharmaceutical compositions, methods of treatment, and synthetic methods are provided.
Yangbo Feng - Palm Beach Gardens FL, US Philip LoGrasso - Jupiter FL, US Thomas Bannister - Palm Beach Gardens FL, US Thomas Schroeter - Riviera Beach FL, US Yen Ting Chen - Palm Beach Gardens FL, US Yan Yin - Jupiter FL, US Hampton Sessions - Orlando FL, US Michael P. Smolinski - Port St. Lucie FL, US Lei Yao - Tianjin, CN Bo Wang - Collegeville PA, US Bozena Frackowiak-Wojtasek - Wielki, PL
Compounds useful as Rho kinase inhibitors of formula (1) wherein the variables are as defined herein are provided. Methods of treatment of malconditions mediated by Rho kinase, and methods of preparation of the compounds, are also provided.
Substituted Pyrimidinyl-Amines As Protein Kinase Inhibitors
Theodore Mark Kamenecka - Palm Beach Gardens FL, US Rong Jiang - Fuquay Varina NC, US Xinyi Song - Jupiter FL, US Philip LoGrasso - Jupiter FL, US Michael Darin Cameron - Port Saint Lucie FL, US Derek R. Duckett - Jupiter FL, US
The present invention provides novel substituted pyrimidinyl-amines that are useful as inhibitors of protein kinases, especially c-Jun N-terminal kinases (JNK) and pharmaceutical compositions thereof and methods of using the same for treating conditions responsive to the inhibition of the JNK pathway.
The present invention is directed to modulators, such as inhibitors, of JNK isoform 2 (JNK2) or isoform 3 (JNK3) comprising compounds of formula (I) or formula (II) as described herein. Compounds of the invention can be used for treatment of a medical disorder in a patient wherein modulation of JNK3 is medically indicated, such as when the disorder is Parkinson disease (PD) Alzheimer's disease (AD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), myocardial infarction (MI), glaucoma, obesity, diabetes, cancer, rheumatoid arthritis, fibrotic disease, pulmonary fibrosis, kidney disease, liver inflammation, Crohns disease, hearing loss, Prader Willi syndrome, or a condition where modification of feeding behavior is medically indicated.
Substituted Pyrimidinyl-Amines As Protein Kinase Inhibitors
- La Jolla CA, US Rong Jiang - Fuquay Varina NC, US Xinyi Song - Jupiter FL, US Philip LoGrasso - Jupiter FL, US Michael Darin Cameron - Port Saint Lucie FL, US Derek R. Duckett - Jupiter FL, US
The present invention provides novel substituted pyrimidinyl-amines that are useful as inhibitors of protein kinases, especially c-Jun N-terminal kinases (JNK) and pharmaceutical compositions thereof and methods of using the same for treating conditions responsive to the inhibition of the JNK pathway.
Name / Title
Company / Classification
Phones & Addresses
Philip Lograsso
Stem Cell Vet Therapy, LLC Specialty Outpatient Clinic
777 S Flagler Dr, West Palm Beach, FL 33401
Philip Lograsso
MEALS ON WHEELS OF THE PALM BEACHES, INC
1300 S Olive Ave, West Palm Beach, FL 33401 West Palm Beach, FL 33402 118 Segovia Way, Jupiter, FL 33458
Philip Lograsso Director
ABACOA PARTNERSHIP FOR COMMUNITY, INC Social Services
The Scripps Research Institute (Non-Profit; Research industry): Professor, Molecular Therapeutics, and Sr. Direcetor Drug Discovery, (July 2005-Present) Oversee group of 35 biologists and chemists working on drug discovery projects in CNS, metabolic disease, and ophthalmology.